Colorado Pharma Co. Investor Sues Over Stock Split, Grant
Biopharmaceutical venture Aytu Biopharma Inc. has been hit with a stockholder derivative suit accusing its CEO and four directors of wrongly awarding themselves more than $10 million in shares while ignoring...To view the full article, register now.
Already a subscriber? Click here to view full article